8-K: SS&C Technologies Announces Strong Q2 2024 Results and $1 Billion Share Repurchase Program

SS&C Technologies reported a strong second quarter with revenue and earnings growth, and announced a $1 billion stock repurchase program.

Summary

• SS&C Technologies announced its financial results for the second quarter ended June 30, 2024, showcasing a 6.5% increase in both GAAP and adjusted revenue, reaching $1,451.5 million and $1,452.4 million respectively.
• The company's GAAP diluted earnings per share rose by 47.1% to $0.75, while adjusted diluted earnings per share increased by 17.6% to $1.27.
• SS&C's net income attributable to SS&C was $190.3 million, a 45.6% increase, and adjusted consolidated EBITDA was $558.9 million, up 11.2%.
• The company repurchased 3.7 million shares for $227.0 million during the quarter, at an average price of $62.17 per share, marking the highest share buyback in the company's history.
• SS&C's Board of Directors authorized a renewal of the stock repurchase program, allowing the company to repurchase up to $1 billion of its outstanding shares.
• The company's operating cash flow for the six months ended June 30, 2024, was $565.4 million, a 3.2% decrease compared to the same period in 2023.
• SS&C ended the second quarter with $462.7 million in cash and cash equivalents and $6,653.1 million in gross debt.
• The company's net leverage ratio stood at 2.84 times consolidated EBITDA, and the net secured leverage ratio was 1.60 times consolidated EBITDA as of June 30, 2024.
• SS&C provided guidance for Q3 2024, projecting adjusted revenue between $1,420.0 and $1,460.0 million and adjusted diluted earnings per share between $1.21 and $1.27.
• For the full year 2024, SS&C expects adjusted revenue between $5,706.2 and $5,866.2 million and adjusted diluted earnings per share between $4.98 and $5.22.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, significant share buybacks, and positive management commentary. The company's growth metrics and future guidance are encouraging, although there are some risks and debt concerns.

Positives

• SS&C experienced strong revenue growth in Q2 2024, with both GAAP and adjusted revenue increasing by 6.5%.
• The company's earnings per share saw significant growth, with GAAP diluted EPS up 47.1% and adjusted diluted EPS up 17.6%.
• SS&C's net income and adjusted consolidated EBITDA also showed substantial increases, indicating improved profitability.
• The company's aggressive share buyback program demonstrates confidence in its stock value and commitment to shareholder returns.
• The renewal of the $1 billion stock repurchase program signals continued focus on maximizing shareholder value.
• The company's operating cash flow increased by 16.8% for the three months ended June 30, 2024.
• SS&C's organic revenue growth of 6.4% indicates strong underlying business performance.
• The company's financial services recurring revenue growth of 7.7% shows a stable and growing revenue base.

Negatives

• Operating cash flow for the six months ended June 30, 2024, decreased by 3.2% compared to the same period in 2023.
• The company has a significant amount of gross debt, totaling $6,653.1 million as of June 30, 2024.
• SS&C's net leverage ratio is 2.84 times consolidated EBITDA, indicating a considerable debt burden.
• The healthcare segment experienced a decline in adjusted organic revenue growth, with a decrease of 4.8% in Q2 2024.

Risks

• The company's forward-looking statements are subject to various risks and uncertainties, including economic conditions, industry competition, and regulatory changes.
• SS&C's substantial indebtedness could impact its financial flexibility and ability to pursue growth opportunities.
• The company's business is exposed to fluctuations in customer demand and the variability of revenue due to activity in the securities markets.
• There are risks associated with the company's foreign operations, including currency fluctuations and regulatory compliance.
• The company faces risks related to the protection of its intellectual property and potential litigation.
• The company's ability to realize anticipated benefits from acquisitions is not guaranteed.
• The company's reliance on the hedge fund industry could expose it to risks associated with that sector.
• The company's guidance for future periods is based on estimates and assumptions that may not materialize.

Future Outlook

SS&C provided guidance for Q3 2024 and full year 2024, projecting adjusted revenue between $1,420.0 and $1,460.0 million for Q3 and between $5,706.2 and $5,866.2 million for the full year. Adjusted diluted earnings per share are projected to be between $1.21 and $1.27 for Q3 and between $4.98 and $5.22 for the full year.

Management Comments

• Bill Stone, Chairman and Chief Executive Officer, stated that SS&C's momentum continued into the second quarter, with 6.4% organic revenue growth and $1.27 in adjusted diluted EPS, up 17.6%.
• Bill Stone also mentioned that the strong results in the first half of 2024 are indicative of the work put in over the last few years.
• Management indicated they will continue to be aggressive with stock buybacks as long as they feel the stock is undervalued, with the goal of maximizing long-term shareholder value.

Industry Context

SS&C's results reflect a positive trend in the financial technology sector, with strong growth in recurring revenue and adjusted earnings. The company's focus on software and software-enabled services aligns with the increasing demand for technology solutions in the financial and healthcare industries. The stock repurchase program is a common strategy among mature tech companies to return value to shareholders.

Comparison to Industry Standards

• SS&C's 6.5% revenue growth is solid compared to peers in the financial software sector, such as Fiserv and Jack Henry & Associates, which have seen growth in the mid-single digits.
• The 17.6% growth in adjusted diluted EPS is strong, indicating efficient cost management and operational improvements, outperforming some competitors who have seen lower earnings growth.
• The $1 billion share repurchase program is a significant move, comparable to other large tech companies that use buybacks to enhance shareholder value, such as Oracle and Microsoft.
• SS&C's net leverage ratio of 2.84x is within the range of other companies in the sector, but the company's focus on debt reduction is a positive sign.
• The company's organic growth of 6.4% is a good indicator of the underlying health of the business, and is comparable to other software companies that have seen similar organic growth rates.

Stakeholder Impact

• Shareholders will benefit from the increased earnings per share and the stock repurchase program.
• Employees may see increased job security and potential for career growth due to the company's strong performance.
• Customers will likely benefit from the company's continued investment in technology and services.
• Suppliers and creditors will likely see a stable and reliable business partner.

Next Steps

• SS&C will host a 2024 Analyst Day on September 18th in New York City.
• SS&C Deliver, the annual client conference, will be held October 6-8 in New Orleans.
• The company will continue to execute its stock repurchase program.
• Management will continue to evaluate market conditions and other factors to determine the timing and amount of share repurchases.

Key Dates

Keywords

Financial Software, Investment Management, Healthcare Software, Share Repurchase, Earnings Results, Revenue Growth, EBITDA, Operating Income, Financial Services, Organic Growth